CID 135606921

N'-(3-allyl-2-hydroxybenzylidene)-2-(2-me-1h-benzimidazol-1-yl)acetohydrazide

Structural Information

Molecular Formula
C20H20N4O2
SMILES
CC1=NC2=CC=CC=C2N1CC(=O)N/N=C/C3=CC=CC(=C3O)CC=C
InChI
InChI=1S/C20H20N4O2/c1-3-7-15-8-6-9-16(20(15)26)12-21-23-19(25)13-24-14(2)22-17-10-4-5-11-18(17)24/h3-6,8-12,26H,1,7,13H2,2H3,(H,23,25)/b21-12+
InChIKey
LFDFUWQLVHFVMJ-CIAFOILYSA-N
Compound name
N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]-2-(2-methylbenzimidazol-1-yl)acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

348.15863 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 349.16591 184.3
[M+Na]+ 371.14785 197.1
[M+NH4]+ 366.19245 190.1
[M+K]+ 387.12179 191.3
[M-H]- 347.15135 187.7
[M+Na-2H]- 369.13330 190.8
[M]+ 348.15808 186.9
[M]- 348.15918 186.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.